Treating hypertension – a new approach
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians.
Research has indicated that a new pharmacological...
PSA’s projects make a bigger impact than ever before
The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.
Depression and complementary medicines
Around one in 16 Australians will suffer from depression at some time during their life.1,2 What evidence is there that complementary medicines such as S-Adenosyl-L-methionine...
Experts urge support for PrEP after second Australian HIV case
Experts are emphasising the efficacy of the revolutionary pre-exposure prophylaxis (PrEP) medicine after a recent case of a Sydney man contracting HIV while taking...
Hotline data reveals Australians’ pharmacy questions
What are the health questions Australian most want answers to? Data from Medicines Line, the NPS MedicineWise pharmacist-staffed information hotline, has revealed common medical...
Call for pharmacist access to the MBS for Chronic Disease Management
Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense.
After a...
